Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Type II Endoleak With ANEUFIX: Assessment of Safety, Performance and Clinical Benefit.

NCT03918460 is registered in ClinicalTrials.gov with TripleMed B.V. as lead sponsor.

NCT NCT03918460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Type II Endoleak With ANEUFIX: Assessment of Safety, Performance and Clinical Benefit.
Lead sponsor
TripleMed B.V.
Phase
Not applicable
Overall status
Unknown status
Start date
May 13, 2020
Completion date
February 28, 2026
Enrollment
40 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, endoleak